Jacobson JO - Search Results

1

Acquired Resistance to KRAS^G12C Inhibition in Cancer.

Awad MM, Liu S, Rybkin II, Arbour KC, Dilly J, Zhu VW, Johnson ML, Heist RS, Patil T, Riely GJ, Jacobson JO, Yang X, Persky NS, Root DE, Lowder KE, Feng H, Zhang SS, Haigis KM, Hung YP, Sholl LM, Wolpin BM, Wiese J, Christiansen J, Lee J, Schrock AB, Lim LP, Garg K, Li M, Engstrom LD, Waters L, Lawson JD, Olson P, Lito P, Ou SI, Christensen JG, Jänne PA, Aguirre AJ. Awad MM, et al. Among authors: jacobson jo. N Engl J Med. 2021 Jun 24;384(25):2382-2393. doi: 10.1056/NEJMoa2105281. N Engl J Med. 2021. PMID: 34161704 Free PMC article.

2

A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib.

Schneider JL, Muzikansky A, Lin JJ, Krueger EA, Lennes IT, Jacobson JO, Cheng M, Heist RS, Piotrowska Z, Gainor JF, Shaw AT, Dagogo-Jack I. Schneider JL, et al. Among authors: jacobson jo. JTO Clin Res Rep. 2022 Jun 8;3(7):100347. doi: 10.1016/j.jtocrr.2022.100347. eCollection 2022 Jul. JTO Clin Res Rep. 2022. PMID: 35815322 Free PMC article.

3

Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non-Small-Cell Lung Cancer.

Jackman DM, Zhang Y, Dalby C, Nguyen T, Nagle J, Lydon CA, Rabin MS, McNiff KK, Fraile B, Jacobson JO. Jackman DM, et al. Among authors: jacobson jo. J Oncol Pract. 2017 Apr;13(4):e346-e352. doi: 10.1200/JOP.2017.021741. Epub 2017 Mar 4. J Oncol Pract. 2017. PMID: 28260402

4

Suffering, Systems, and Safety: Applying the Principles of Systems Safety to Improve the Care of Patients With Cancer.

Jacobson JO. Jacobson JO. JCO Oncol Pract. 2020 Mar;16(3):115-120. doi: 10.1200/JOP.19.00646. Epub 2020 Jan 7. JCO Oncol Pract. 2020. PMID: 32048947 No abstract available.

5

Accompanying Patients in the Time of COVID-19.

Jacobson JO. Jacobson JO. JAMA Oncol. 2021 Jul 1;7(7):971-972. doi: 10.1001/jamaoncol.2021.1311. JAMA Oncol. 2021. PMID: 34014248 No abstract available.

6

COVID-19 and Cancer Care: Ensuring Safety While Transforming Care Delivery.

Mulvey TM, Jacobson JO. Mulvey TM, et al. Among authors: jacobson jo. J Clin Oncol. 2020 Oct 1;38(28):3248-3251. doi: 10.1200/JCO.20.01474. Epub 2020 Aug 4. J Clin Oncol. 2020. PMID: 32749939 No abstract available.

7

Early Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care.

Jackman DM, Foster E, Hamilton JM, Tremonti C, Bunnell CA, Stuver SO, Jacobson JO. Jackman DM, et al. Among authors: jacobson jo. Am J Med Qual. 2022 Mar-Apr 01;37(2):103-110. doi: 10.1097/01.JMQ.0000749852.10699.bc. Am J Med Qual. 2022. PMID: 34108394

8

Who Is MB and What Does She Want?

Jacobson JO. Jacobson JO. J Clin Oncol. 2022 Feb 1;40(4):427-429. doi: 10.1200/JCO.21.02069. Epub 2021 Nov 18. J Clin Oncol. 2022. PMID: 34793250 No abstract available.

9

How Safe Is Cancer Care?

Jacobson JO, Cox JV, Peppercorn J. Jacobson JO, et al. JCO Oncol Pract. 2022 Dec;18(12):840-842. doi: 10.1200/OP.22.00450. Epub 2022 Sep 1. JCO Oncol Pract. 2022. PMID: 36049145

10

Chronic Comorbidity Among Patients With Cancer: An Impetus for Oncology and Primary Care Collaboration.

Rotenstein LS, Zhang Y, Jacobson JO. Rotenstein LS, et al. Among authors: jacobson jo. JAMA Oncol. 2019 Aug 1;5(8):1099-1100. doi: 10.1001/jamaoncol.2019.1601. JAMA Oncol. 2019. PMID: 31268490 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page